Showing posts with label meta-analysis. Show all posts
Showing posts with label meta-analysis. Show all posts

Thursday, September 28, 2017

Prophylactic negative pressure wound therapy may help cut down surgical wound infections after cesarean


Prophylactic negative pressure wound therapy (NPWT) at cesarean delivery may reduce the surgical site infections (SSI) and overall wound complications says the results of a systematic review and meta-analysis published ahead of print in American journal of obstetrics and gynecology.

Morbidly obese women have a very high rate of SSIs and readmission to hospitals.
The researchers conducted a literature review and included RCTs and observational studies comparing surgical outcome between prophylactic negative pressure wound closure and standard cesarean wound closure.  

The investigators were mainly looking at difference in SSI because of NPWT besides other minor outcomes like composite wound complications, wound gaping, hematoma, endometritis and readmission to the hospital.

Six RCTs and three cohort study met the inclusion criteria. It was seen that women with NPWT faced a 55% lower risk of SSI as compared to women with standard dressing (pooled RR 0.45; 95% CI 0.31- 0.66). The Number Need to Treat (NNT) was 17.

Women with NPWT also had a 22 lower risk of composite wound complications, while the other minor outcomes were comparable in both the groups.

The authors concluded that although the studies were heterogenous, use of NPWT decreases the SSIs after  cesarean, larger clinical trials are awaited to fully understand the impact of the intervention.


For more news visit Facebook and Twitter





Monday, September 11, 2017

Continuing and Robust decline in sperm count in men signals catastrophic implications beyond fertility.


Courtesy: bbc.com 

A huge systematic review and meta-analysis has found a continuing decline in sperm count by an average 1.4% per year among western men between the year 1973 to 2011. The results made headlines and were published 25 July 2017 in Journal of Human Reproduction Updates. The decline of 50% in four decades was so significant that the study results made headlines.

Hagai Levine, the lead researcher and faculty member of the Braun School of Public Health and Community Medicine at Hebrew University-Hadassah in Jerusalem says, “This is a wake-up call to study the causes of this decline, aiming to prevent further deterioration.” 

Whether sperm counts have declined or not is debated since very long and the controversy remains fluid because of limited number of studies addressing this issue.

Besides being the first step in diagnosing male factor infertility, sperm count is of considerable public health importance. Reduced sperm count is a predictor of high all-cause morbidity and mortality, besides incurring a high financial burden on the society. It is also linked to a range of male reproductive problems like cryptorchidism, hypospadias, testicular cancer, low testosterone levels and increased utilization of Assisted Reproductive Techniques.  There has been a 65% increase in IVF treatments since 2003 according to a survey results of young US adults by the Reproductive Medicine Associates of New Jersey.

Low Sperm Counts is also a mirror of environmental influences on our endocrine system because of modern life style. They reflect the influence of endocrine disrupting chemicals, pesticides, changes in environmental temperature and life style factors like smoking, diet, stress and BMI.

The researchers identified 7518 studies meeting the study protocols, from which 185 studies amounting to nearly 43000 subjects who provided samples between 1973–2011 were selected for final analysis.

Data was available across 6 continents and nearly 50 countries.

For final analyses, the countries were grouped into ‘Western’ including studies from North America, Europe, Australia and New Zealand and ‘Other’/ ‘Non-Western’ including studies from all other countries like South America, Asia and Africa.

Meta- regression analyses showed that mean sperm concentration (SC) was 81 million/ml, the mean total sperm count (TSC) was 260 million and the mean year of data sample collection was 1995.

Sperm concentrations declined by 50% and total sperm count by nearly 60% over the years among men unselected by fertility primarily from North America, Europe, Australia and New Zealand. The study saw no significant declines for studies from South America, Asia and Africa, possibly because of limited number of studies available from these geographic areas. 

The statistic reflects the fact that an increasing number of men will have sperm counts below any given threshold for sub-fertility or infertility. Quite a large percentage of Western men have concentration below 40 million/ml, decreasing the probability of natural conception.

This decline remained unchanged after controlling for various confounders like age, abstinence time, method of semen collection, method of counting sperm, selection of population and study exclusion criteria, number of samples per man and completeness of data.

While it is not possible to rule out the falling trend in semen parameters in non-western countries it is certain that the decline is not as steep as observed for their western counterparts.

The continuing decline of sperm count in western males is regarded as ‘canary in the coalmine’ for male health across the life span and calls for more studies and research urgently to put a stop to this damning trend.

Article Full Text


Friday, February 19, 2016

Serum Biomarkers to predict outcome in women with threatened abortion: A systemic review and diagnostic accuracy meta-analysis.




Threatened abortion approximately affect 20% of pregnancies and 50% of those will end up in miscarriage.  It has also been associated with poor obstetric outcome such as preterm labor, low lying placenta, low birth weight and PROM.

The uncertainty of prognosis makes it a challenging task for healthcare professionals.Various biomarkers have been used, with variable results to predict the prognosis of bleeding in early pregnancy.

This systemic review and meta-analysis was published in the forthcoming issue of Human Reproduction update, it aims to determine the diagnostic accuracy of various biomarkers.

A total of 19 studies were found after electronic searching of databases to determine outcomes for women with threatened abortion at 5–23 weeks gestational age.

15 studies (including 1263 women) were found eligible using QUADAS-2 (Quality Assessment for Diagnostic Accuracy Studies-2: A Revised Tool) to include in the qualitative data assessment.

The biomarkers that were looked into included serum progesterone, hCG, pregnancy associated plasma protein A, estradiol and cancer antigen 125 (CA 125).

Interestingly, serum CA 125 appeared to be the most promising marker (n = 648 women, 7 studies), whereas serum progesterone and hCG are less useful once fetal viability is established.

CA-125 is a glycoprotein and its origin is uncertain during pregnancy. It arises during the first trimester and return to a non-pregnancy range in late pregnancy.

CA 125 showed a sensitivity of 90% (95% confidence interval (CI) 83–94%), specificity of 88% (95% CI 79–93%), positive likelihood ratio of 7.86 (95% CI 4.23–14.60) and negative likelihood ratio of 0.10 (95% CI 0.06–0.20). The inverse of negative likelihood ratio was 9.31 (95% CI 5–17.1) indicating that a negative test is likely to identify those who are likely to continue with the pregnancy.

Nevertheless, when vaginal bleeding had been present for 3 days or more and there was high maternal serum CA125 activity, the abortion risk was found to be 100%.

Since this was a qualitative analysis, no cut-off value for CA125 was determined but in most studies patients who eventually aborted had values of CA-125 more than 125 IU/ml while the control had a value not more than 93 IU/ml.

A rising value of CA 125 combined with gestational sac diameter that does not correspond to the pregnancy dating is highly significant in predicting the prognosis.

Serum estradiol was the next best marker with a sensitivity of 45% (95% CI 6–90%), a specificity of 87% (95% CI 81–92%), a positive likelihood ratio of 3.72 (95% CI 1.01–13.71) and a negative likelihood ratio of 0.62 (95% CI 0.20–1.84).


References:

https://humupd.oxfordjournals.org/content/22/2/228.abstract 

https://www.researchgate.net/publication/21703609_The_prognostic_significance_of_maternal_serum_CA125_measurement_in_threatened_abortion.





http://www.ncbi.nlm.nih.gov/pubmed/12235698